Overview
Saori Miwa practices in Tokyo, Japan. Ms. Miwa is highly rated in 1 condition, according to our data. Her top areas of expertise are Acute Nephritic Syndrome, Poststreptococcal Glomerulonephritis, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidoses (MPS).
Her clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Nephritic SyndromeMs. Miwa isAdvanced. Learn about Acute Nephritic Syndrome.
- Experienced
- Alport SyndromeMs. Miwa isExperienced. Learn about Alport Syndrome.
- Autosomal Dominant Tubulointerstitial Kidney Disease
- Congenital Heart Disease (CHD)Ms. Miwa isExperienced. Learn about Congenital Heart Disease (CHD).
- Congenital Myasthenic SyndromeMs. Miwa isExperienced. Learn about Congenital Myasthenic Syndrome.
- Mucopolysaccharidoses (MPS)Ms. Miwa isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)